18.02.2022 Nalu Medical Inc. Announces $104 Million Equity Financing

Press Release
16.02.2022Curve Therapeutics Announces Collaboration with MSD for Next Generation Drug Discovery Platform

Press Release
11.01.2022Amgen and Arrakis Therapeutics Announce Multi-Target Collaboration to Identify Novel RNA Degrader Small Molecule Therapeutics

Press Release
15.12.2021Artax Biopharma Announces First-in-Human Dosing in Phase 1 Clinical Trial for AX-158, Company’s First-in-Class Oral Immunomodulator to Treat T Cell-Mediated Diseases

Press Release
06.12.2021Amphista Therapeutics Appoints Dr Martin Pass as CDO

Press Release
02.12.2021AviadoBio™ Raises $80 million in Series A Financing to Advance Neurodegenerative Gene Therapy Platform

Press Release
02.12.2021Highlight Therapeutics & Cima announce positive results from pre-clinical study combining BO-112 + STING agonist published in Journal for ImmunoTherapy of Cancer

Press Release
15.11.2021Aura Biosciences Presents Final Phase 1b/2 Data for its first Virus-Like Drug Conjugate, AU-011, in Patients with Choroidal Melanoma at the American Academy of Ophthalmology

Press Release
12.11.2021Highlight Therapeutics announces positive preliminary results from Phase 2b study of BO-112 + anti-PD1 in confirmed anti-PD1 progressor melanoma patients at SITC

Press Release
01.11.2021Amphista Therapeutics Appoints CBO, Beverley Carr

Press Release